Dr. Marco Tubb

Marco Tubb is a researcher in infectious diseases with a focus on antimicrobial resistance and hospital-acquired infections. His work is closely aligned with clinical epidemiology, particularly in the context of healthcare settings where resistant organisms pose significant risks. He is associated with research contributing to the Southern African infectious disease landscape.

His published study examines carbapenem-resistant Enterobacterales (CRE), emphasizing colonisation as a precursor to infection. This work highlights the importance of surveillance strategies and early identification of at-risk patients, reflecting a strong interest in infection prevention, risk prediction, and antimicrobial stewardship. The research underscores practical clinical implications for managing resistant pathogens in resource-constrained environments.

Based on limited available publications, his contributions suggest a focused engagement with emerging resistance threats and their clinical consequences. His work supports improved infection control protocols and adds to the growing body of evidence guiding policy and practice in combating antimicrobial resistance.